Description:
Fulzos is a hormonal treatment for advanced or metastatic breast cancer in postmenopausal women. It contains fulvestrant, an estrogen receptor antagonist that degrades the estrogen receptor, preventing estrogen from stimulating cancer cell growth.
Fulzos is administered via intramuscular injection and is effective in patients who have developed resistance to previous hormonal therapies. It offers a unique mechanism of action in the hormone therapy landscape and provides clinical benefits in prolonging progression-free survival.
Share your experience with our medical product. Write a review!
17 Nov 2025
Early Detection Saves Lives: A Parent’s Guide to Preventive Care for Childhood Asthma
When we talk about childhood asthma, it’s not an abstract worry-it’s a very real condition that affects millions of kids worldwide.
17 Nov 2025
The Role of Lifestyle Modifications in Chronic Disease Prevention
Chronic diseases-like type 2 diabetes, heart disease, hypertension, and certain cancers-are no longer just problems for “other people.”
29 Sep 2025
Gut Health and Immunity: Why a Healthy Digestive System is Your First Line of Defense
When most people think of the immune system, they imagine white blood cells, vaccines, or medicines that protect the body from infections.
29 Sep 2025
The Future of Pain Relief: From Traditional Balms to Next-Gen Transdermal Patches
Pain is one of the most common reasons people seek medical attention, whether it’s muscle pain after a long day, joint pain due to arthritis, or chronic conditions that affect daily living.
